SFRP2, His, Cynomolgus
SFRP2, His, Cynomolgus

The purity of SFRP2, His, Cynomolgus is greater than 95% as determined by SEC-HPLC.

SFRP2, His, Cynomolgus

SFRP2, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

SFRP2, His, Cynomolgus

As biomarkers, DNA methylation is used to detect colorectal cancer (CRC) and make assessment of CRC prognosis. The published findings showed the association between the methylation of SFRP1, SFRP2, and WIF1, located in the Wnt signaling pathway, and the prognosis of CRC were not consistent. SFRP1, SFRP2, and WIF1 were frequently hypermethylated in CRC tumor tissues. It was apparent that the promoter hypermethylation of SFRP2 and co-hypermethylation of SFRP1 and SFRP2 might be considered as independent prognostic predictors for survival advantage of postoperative CRC patients.
Z04913
¥72,752.00

Ask us a question
Product Introduction
Species Cynomolgus
Protein Construction
SFRP2 (Leu25-Cys295)
Accession # G8F2Z7		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 32.16 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 33-38 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • SFRP2, His, Cynomolgus
    • SFRP2, His, Cynomolgus

    The purity of SFRP2, His, Cynomolgus is greater than 95% as determined by SEC-HPLC.

  • SFRP2, His, Cynomolgus
    • SFRP2, His, Cynomolgus

    SFRP2, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background As biomarkers, DNA methylation is used to detect colorectal cancer (CRC) and make assessment of CRC prognosis. The published findings showed the association between the methylation of SFRP1, SFRP2, and WIF1, located in the Wnt signaling pathway, and the prognosis of CRC were not consistent. SFRP1, SFRP2, and WIF1 were frequently hypermethylated in CRC tumor tissues. It was apparent that the promoter hypermethylation of SFRP2 and co-hypermethylation of SFRP1 and SFRP2 might be considered as independent prognostic predictors for survival advantage of postoperative CRC patients.
Synonyms sFRP-2; SARP-1; Sarp1; Sdf5; Sfrp2

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.